This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in

Hosted content

GPnotebook hosts a limited amount of content on behalf of third parties. Such content includes microsites (discrete mini-websites) available via the links below. Microsite content is developed by, and is the responsibility of, the sponsoring company. GPnotebook has had no input into the content. To enquire about hosting a microsite resource, please contact us.

  • Two smiling professionals with logos on a yellow background with a golden arrow.

    Promotional content from CSL Seqirus for healthcare professionals in Australia only

    Residual CV risk beyond LDL-C: A practical approach for general practice

    Explore Vazkepa® (icosapent ethyl) as a potential treatment option, designed to address multiple residual CV risk factors and support improved CV outcomes in adult statin-treatment patients with triglycerides ≥1.7 mmol/L and established CV disease or diabetes and at least one other CV risk factor.

    AU-VZKP-26-0060 | July 2026

    Please review Product Information before prescribing. Product Information available at www.tga.gov.au/resources/auspmd/vazkepa or www.cslseqirus.com.au/products.

  • Moderna logo and text "Understanding the mRNA Technology Platform" next to a smiling female scientist wearing a lab coat.

    The content of this website is intended for Australian healthcare professionals only. All content has been funded and developed by Moderna Australia Pty Ltd.

    Understanding the mRNA Technology Platform

    Learn from global experts as they explore how mRNA technology works and how it can help protect patients from infectious diseases.

    AU-NP-MPS-2500001 | January 2026

  • Three separate images depicting joyful interactions across different ages and cultures; a grandmother whispering to a giggling young girl, an elderly Black man adjusting his glasses and smiling, and an elderly Asian couple smiling together, with a logo for Betmiga on the right.

    This promotional site has been organised and funded by Astellas Pharma Australia Pty Ltd. Suite 2.01, 2 Banfield Road, Macquarie Park, NSW 2113. Copyright © 2024. All rights reserved. GPnotebook is the hosting partner for this site and has no input into the content. This site is intended for healthcare professionals in Australia only. This product is not listed on the PBS. Review Product Information before prescribing. Click here for Approved Product Information.

    Practical strategies for supporting urinary tract dysfunction in primary care

    Explore practical strategies and expert insights from Prof. Marcus Drake to support early intervention for lower urinary tract symptoms (LUTS) in primary care.

    MAT-AU-BET-2025-00072 | September 2025